Skip to main content
. 2022 Sep 25;23(19):11307. doi: 10.3390/ijms231911307
aHUS atypical hemolytic–uremic syndrome
APLS antiphospholipid syndrome
AKI acute kidney injury
CNI calcineurin inhibitor
COVID-19 coronavirus disease 2019
ESRD end-stage renal disease
FSGS focal segmental glomerulosclerosis
FFP fresh frozen plasma
HCQ hydroxychloroquine
HCV hepatitis C virus
MAHA microangiopathic hemolytic anemia
PCR polymerase chain reaction
SARS- CoV-2 severe acute respiratory syndrome coronavirus 2
STEC-HUS Shiga toxin-mediated hemolytic uremic syndrome
TMA thrombotic microangiopathy
TPE therapeutic plasma exchange
TTP thrombotic thrombocytopenic purpura
vWF von Willebrand factor